Treatment approaches in primary Sjogren syndrome

JAMA. 2010 Nov 10;304(18):2015-6; author reply 2016. doi: 10.1001/jama.2010.1582.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Humans
  • Randomized Controlled Trials as Topic
  • Rituximab
  • Saliva, Artificial / therapeutic use
  • Sjogren's Syndrome / complications
  • Sjogren's Syndrome / drug therapy*
  • Treatment Outcome
  • Xerostomia / drug therapy

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Saliva, Artificial
  • Rituximab